Cambrian BioPharma Inc 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-04 4:41 pm Sale | 2023-07-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 3,653,120 14.600% | -1,582,836 (-30.23%) | Filing |
| 2023-02-14 11:36 am Purchase | 2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,235,956 17.000% | 4,468 (+0.09%) | Filing |
| 2022-06-10 2:18 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,231,488 17.100% | 5,231,488 (New Position) | Filing |